• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白藜芦醇在间质性肺疾病治疗中的潜力。

Potential of resveratrol in the treatment of interstitial lung disease.

作者信息

Huo Rongxiu, Huang Xinxiang, Yang Yanting, Yang Yang, Lin Jinying

机构信息

Department of Rheumatology and Immunology, Guangxi Academy of Medical Sciences, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.

出版信息

Front Pharmacol. 2023 Apr 6;14:1139460. doi: 10.3389/fphar.2023.1139460. eCollection 2023.

DOI:10.3389/fphar.2023.1139460
PMID:37089962
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10117935/
Abstract

Interstitial lung disease (ILD) is a heterogeneous group of diseases characterized by lung injury caused by lung fibroblast proliferation, interstitial inflammation, and fibrosis. Different cell signal transduction pathways are activated in response to various proinflammatory or fibrotic cytokines, such as IL-6, and these cytokines are increased in different ILDs. The overexpressed cytokines and growth factors in ILD can activate TGF-β/Smad2/3/4, NF-κB, and JAK/STAT signal transduction pathways, promote the activation of immune cells, increase the release of pro-inflammatory and pro-fibrotic factors, differentiate fibroblasts into myofibroblasts, and promote the occurrence and development of ILD. This finding suggests the importance of signal transduction pathways in patients with ILD. Recent evidence suggests that resveratrol (RSV) attenuates excessive inflammation and pulmonary fibrosis by inhibiting the TGF-β/Smad2/3/4, NF-κB, and JAK/STAT signal transduction pathways and overactivation of immune cells. In this review, advances in lung protection and the underlying mechanisms of RSV are summarized, and the potential efficacy of RSV as a promising treatment option for ILD is highlighted.

摘要

间质性肺疾病(ILD)是一组异质性疾病,其特征是由肺成纤维细胞增殖、间质炎症和纤维化引起的肺损伤。针对各种促炎或促纤维化细胞因子(如IL-6),不同的细胞信号转导通路被激活,并且这些细胞因子在不同的ILD中会增加。ILD中过表达的细胞因子和生长因子可激活TGF-β/Smad2/3/4、NF-κB和JAK/STAT信号转导通路,促进免疫细胞的激活,增加促炎和促纤维化因子的释放,使成纤维细胞分化为肌成纤维细胞,并促进ILD的发生和发展。这一发现表明信号转导通路在ILD患者中的重要性。最近的证据表明,白藜芦醇(RSV)通过抑制TGF-β/Smad2/3/4、NF-κB和JAK/STAT信号转导通路以及免疫细胞的过度激活来减轻过度炎症和肺纤维化。在这篇综述中,总结了RSV在肺保护方面的进展及其潜在机制,并强调了RSV作为ILD一种有前景的治疗选择的潜在疗效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8879/10117935/7767bcec07ce/fphar-14-1139460-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8879/10117935/ab48e92811a1/fphar-14-1139460-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8879/10117935/7767bcec07ce/fphar-14-1139460-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8879/10117935/ab48e92811a1/fphar-14-1139460-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8879/10117935/7767bcec07ce/fphar-14-1139460-g002.jpg

相似文献

1
Potential of resveratrol in the treatment of interstitial lung disease.白藜芦醇在间质性肺疾病治疗中的潜力。
Front Pharmacol. 2023 Apr 6;14:1139460. doi: 10.3389/fphar.2023.1139460. eCollection 2023.
2
Systemic treatment with resveratrol alleviates adjuvant arthritis-interstitial lung disease in rats via modulation of JAK/STAT/RANKL signaling pathway.白藜芦醇通过调节 JAK/STAT/RANKL 信号通路缓解佐剂性关节炎-间质性肺病大鼠的系统性治疗。
Pulm Pharmacol Ther. 2019 Jun;56:69-74. doi: 10.1016/j.pupt.2019.03.011. Epub 2019 Mar 28.
3
Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms.JAK/STAT 在间质性肺疾病中的作用;分子和细胞机制。
Int J Mol Sci. 2021 Jun 9;22(12):6211. doi: 10.3390/ijms22126211.
4
Therapeutic Potential of Janus Kinase Inhibitors for the Management of Interstitial Lung Disease.Janus 激酶抑制剂治疗间质性肺病的潜力。
Drug Des Devel Ther. 2022 Apr 2;16:991-998. doi: 10.2147/DDDT.S353494. eCollection 2022.
5
Interstitial Lung Disease in Patients With Systemic Sclerosis: Toward Personalized-Medicine-Based Prediction and Drug Screening Models of Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD).系统性硬化症患者的间质性肺病:基于个体化医学的系统性硬化症相关间质性肺病(SSc-ILD)预测和药物筛选模型。
Front Immunol. 2020 Sep 4;11:1990. doi: 10.3389/fimmu.2020.01990. eCollection 2020.
6
Profibrotic effect of IL-17A and elevated IL-17RA in idiopathic pulmonary fibrosis and rheumatoid arthritis-associated lung disease support a direct role for IL-17A/IL-17RA in human fibrotic interstitial lung disease.IL-17A 和升高的 IL-17RA 在特发性肺纤维化和类风湿关节炎相关肺部疾病中的促纤维化作用支持 IL-17A/IL-17RA 在人类纤维性间质性肺疾病中的直接作用。
Am J Physiol Lung Cell Mol Physiol. 2019 Mar 1;316(3):L487-L497. doi: 10.1152/ajplung.00301.2018. Epub 2019 Jan 3.
7
Pirfenidone mitigates TGF-β1-mediated fibrosis in an idiopathic inflammatory myositis-associated interstitial lung disease model.吡非尼酮可减轻特发性炎症性肌病相关间质性肺病模型中 TGF-β1 介导的纤维化。
Cytokine. 2022 Jun;154:155899. doi: 10.1016/j.cyto.2022.155899. Epub 2022 Apr 30.
8
Anti-fibrotic effects of pirfenidone by interference with the hedgehog signalling pathway in patients with systemic sclerosis-associated interstitial lung disease.吡非尼酮通过干扰刺猬信号通路对系统性硬化症相关间质性肺病患者的抗纤维化作用。
Int J Rheum Dis. 2018 Feb;21(2):477-486. doi: 10.1111/1756-185X.13247. Epub 2018 Jan 7.
9
Combined anti-fibrotic and anti-inflammatory properties of JAK-inhibitors on macrophages in vitro and in vivo: Perspectives for scleroderma-associated interstitial lung disease.JAK 抑制剂对体外和体内巨噬细胞的抗纤维化和抗炎特性:硬皮病相关间质性肺疾病的展望。
Biochem Pharmacol. 2020 Aug;178:114103. doi: 10.1016/j.bcp.2020.114103. Epub 2020 Jun 17.
10
3,3'-Diindolylmethane attenuates inflammation and fibrosis in radiation-induced lung injury by regulating NF-κB/TGF-β/Smad signaling pathways.3,3'-二吲哚甲烷通过调控 NF-κB/TGF-β/Smad 信号通路减轻放射性肺损伤中的炎症和纤维化。
Exp Lung Res. 2022 Apr;48(3):103-113. doi: 10.1080/01902148.2022.2052208. Epub 2022 May 20.

引用本文的文献

1
Role of Interleukin-6 in Rheumatoid Arthritis-Associated Interstitial Lung Disease: Focus on the JAK/STAT Pathway and Macrophage Polarization.白细胞介素-6在类风湿关节炎相关间质性肺疾病中的作用:聚焦于JAK/STAT途径和巨噬细胞极化
J Inflamm Res. 2025 Aug 13;18:10953-10967. doi: 10.2147/JIR.S530754. eCollection 2025.
2
Resveratrol Supplementation in Wet AMD: Association With Fewer Intravitreal Injections and Reduced Macular Fibrosis.补充白藜芦醇治疗湿性年龄相关性黄斑变性:与减少玻璃体内注射次数及减轻黄斑纤维化相关
Clin Ophthalmol. 2025 Jan 21;19:217-225. doi: 10.2147/OPTH.S494595. eCollection 2025.
3
Interrelation of Natural Polyphenol and Fibrosis in Diabetic Nephropathy.

本文引用的文献

1
T cells in idiopathic pulmonary fibrosis: crucial but controversial.特发性肺纤维化中的T细胞:至关重要但存在争议。
Cell Death Discov. 2023 Feb 14;9(1):62. doi: 10.1038/s41420-023-01344-x.
2
Resveratrol Ameliorates Fibrosis in Rheumatoid Arthritis-Associated Interstitial Lung Disease via the Autophagy-Lysosome Pathway.白藜芦醇通过自噬溶酶体通路改善类风湿关节炎相关间质性肺病的纤维化。
Molecules. 2022 Dec 2;27(23):8475. doi: 10.3390/molecules27238475.
3
Resveratrol alleviates bleomycin-induced pulmonary fibrosis by inhibiting epithelial-mesenchymal transition and down-regulating TLR4/NF-κB and TGF-β1/smad3 signalling pathways in rats.
天然多酚与糖尿病肾病纤维化的相互关系
Molecules. 2024 Dec 25;30(1):20. doi: 10.3390/molecules30010020.
4
A Narrative Review of Key Risk Factors for Severe Illness Following SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus Infection.关于新型冠状病毒、流感病毒和呼吸道合胞病毒感染后重症关键危险因素的叙述性综述
Infect Dis Ther. 2025 Jan;14(Suppl 1):39-61. doi: 10.1007/s40121-024-01081-3. Epub 2024 Dec 30.
5
Dihydroquercetin-Loaded Liposomes Change Fibrous Tissue Distribution in the Bleomycin-Induced Fibrosis Model.载有二氢槲皮素的脂质体改变博来霉素诱导的纤维化模型中的纤维组织分布。
Acta Naturae. 2024 Apr-Jun;16(2):40-49. doi: 10.32607/actanaturae.27440.
6
Researching New Drug Combinations with Senolytic Activity Using Senescent Human Lung Fibroblasts MRC-5 Cell Line.使用衰老的人肺成纤维细胞MRC-5细胞系研究具有衰老细胞溶解活性的新药组合
Pharmaceuticals (Basel). 2024 Jan 4;17(1):70. doi: 10.3390/ph17010070.
7
Perspectives on Post-COVID-19 Pulmonary Fibrosis Treatment.新型冠状病毒肺炎后肺纤维化治疗的观点
J Pers Med. 2023 Dec 29;14(1):51. doi: 10.3390/jpm14010051.
白藜芦醇通过抑制上皮-间质转化以及下调 TLR4/NF-κB 和 TGF-β1/smad3 信号通路缓解博来霉素诱导的大鼠肺纤维化。
Tissue Cell. 2022 Dec;79:101953. doi: 10.1016/j.tice.2022.101953. Epub 2022 Oct 7.
4
Piceatannol-mediated JAK2/STAT3 signaling pathway inhibition contributes to the alleviation of oxidative injury and collagen synthesis during pulmonary fibrosis.白藜芦醇通过抑制 JAK2/STAT3 信号通路缓解肺纤维化过程中的氧化损伤和胶原合成。
Int Immunopharmacol. 2022 Oct;111:109107. doi: 10.1016/j.intimp.2022.109107. Epub 2022 Aug 3.
5
Antifibrotic Mechanism of Piceatannol in Bleomycin-Induced Pulmonary Fibrosis in Mice.白藜芦醇对博来霉素诱导的小鼠肺纤维化的抗纤维化机制
Front Pharmacol. 2022 Jun 7;13:771031. doi: 10.3389/fphar.2022.771031. eCollection 2022.
6
Therapeutic Potential of Janus Kinase Inhibitors for the Management of Interstitial Lung Disease.Janus 激酶抑制剂治疗间质性肺病的潜力。
Drug Des Devel Ther. 2022 Apr 2;16:991-998. doi: 10.2147/DDDT.S353494. eCollection 2022.
7
Resveratrol and Immune Cells: A Link to Improve Human Health.白藜芦醇与免疫细胞:改善人类健康的关联。
Molecules. 2022 Jan 10;27(2):424. doi: 10.3390/molecules27020424.
8
A Comprehensive Analysis of the Efficacy of Resveratrol in Atherosclerotic Cardiovascular Disease, Myocardial Infarction and Heart Failure.白藜芦醇在动脉粥样硬化性心血管疾病、心肌梗死和心力衰竭中的疗效的综合分析。
Molecules. 2021 Oct 31;26(21):6600. doi: 10.3390/molecules26216600.
9
TSSK4 upregulation in alveolar epithelial type-II cells facilitates pulmonary fibrosis through HSP90-AKT signaling restriction and AT-II apoptosis.TSSK4 在肺泡上皮细胞 II 型中的上调通过 HSP90-AKT 信号限制和 AT-II 细胞凋亡促进肺纤维化。
Cell Death Dis. 2021 Oct 13;12(10):938. doi: 10.1038/s41419-021-04232-3.
10
Management of patients with fibrosing interstitial lung diseases.纤维化间质性肺疾病患者的管理。
Am J Health Syst Pharm. 2022 Jan 24;79(3):129-139. doi: 10.1093/ajhp/zxab375.